NCT00117897View on ClinicalTrials.gov

Treatment for Subjects With Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

July 31, 2002

Study Completion Date

February 29, 2004

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG

pegfilgrastim

DRUG

Filgrastim

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY